| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | CTP synthase activity | 4.21e-05 | 2 | 130 | 2 | GO:0003883 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid beta-oxidation | 1.37e-05 | 24 | 128 | 4 | GO:0031998 | |
| GeneOntologyBiologicalProcess | 'de novo' CTP biosynthetic process | 3.82e-05 | 2 | 128 | 2 | GO:0044210 | |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | 4.32e-05 | 266 | 128 | 9 | GO:0033044 | |
| GeneOntologyBiologicalProcess | positive regulation of fatty acid beta-oxidation | 6.38e-05 | 13 | 128 | 3 | GO:0032000 | |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 7.83e-05 | 114 | 128 | 6 | GO:0050772 | |
| GeneOntologyBiologicalProcess | chromosome organization | SMG1 NCAPD3 ERCC4 SLF1 KAT6A NUMA1 ESCO1 ITPA RIF1 WDHD1 CDC16 CDC6 TASOR TOP3B | 9.36e-05 | 686 | 128 | 14 | GO:0051276 |
| GeneOntologyCellularComponent | cytoophidium | 1.09e-04 | 3 | 127 | 2 | GO:0097268 | |
| Domain | FN3_dom | 1.08e-05 | 209 | 124 | 9 | IPR003961 | |
| Domain | Ig-like_fold | PAPPA2 TRIO KALRN L1CAM IL20RA SLC4A2 MST1R HMCN1 PTPRM ROBO2 ASTN1 ADGRF3 PLXNA1 PLXNA2 IL23R IL7R | 1.78e-05 | 706 | 124 | 16 | IPR013783 |
| Domain | CTP_synthase_N | 4.37e-05 | 2 | 124 | 2 | IPR017456 | |
| Domain | GATase1_CTP_Synthase | 4.37e-05 | 2 | 124 | 2 | IPR033828 | |
| Domain | CTP_synthase | 4.37e-05 | 2 | 124 | 2 | IPR004468 | |
| Domain | CTP_synth_N | 4.37e-05 | 2 | 124 | 2 | PF06418 | |
| Domain | FN3 | 5.53e-05 | 199 | 124 | 8 | PS50853 | |
| Domain | Clathrin/coatomer_adapt-like_N | 1.23e-04 | 15 | 124 | 3 | IPR002553 | |
| Domain | Adaptin_N | 1.23e-04 | 15 | 124 | 3 | PF01602 | |
| Domain | Arp3_met | 1.31e-04 | 3 | 124 | 2 | IPR015623 | |
| Domain | FBN | 1.31e-04 | 3 | 124 | 2 | IPR011398 | |
| Domain | - | PAPPA2 TRIO KALRN L1CAM IL20RA MST1R HMCN1 PTPRM ROBO2 ASTN1 PLXNA1 PLXNA2 IL23R IL7R | 1.31e-04 | 663 | 124 | 14 | 2.60.40.10 |
| Domain | PSI | 2.05e-04 | 44 | 124 | 4 | IPR016201 | |
| Domain | FN3 | 2.37e-04 | 185 | 124 | 7 | SM00060 | |
| Domain | PSI | 2.43e-04 | 46 | 124 | 4 | SM00423 | |
| Domain | Neural_cell_adh | 2.60e-04 | 4 | 124 | 2 | IPR009138 | |
| Domain | HAT_MYST-type | 4.32e-04 | 5 | 124 | 2 | IPR002717 | |
| Domain | MOZ_SAS | 4.32e-04 | 5 | 124 | 2 | PF01853 | |
| Domain | GATase | 4.32e-04 | 5 | 124 | 2 | PF00117 | |
| Domain | MYST_HAT | 4.32e-04 | 5 | 124 | 2 | PS51726 | |
| Domain | ARM-type_fold | 4.38e-04 | 339 | 124 | 9 | IPR016024 | |
| Domain | Spectrin | 4.59e-04 | 23 | 124 | 3 | PF00435 | |
| Domain | GOLGA6L | 6.45e-04 | 6 | 124 | 2 | IPR026737 | |
| Domain | GATASE_TYPE_1 | 6.45e-04 | 6 | 124 | 2 | PS51273 | |
| Domain | GATASE | 6.45e-04 | 6 | 124 | 2 | IPR017926 | |
| Domain | cEGF | 6.64e-04 | 26 | 124 | 3 | PF12662 | |
| Domain | cEGF | 6.64e-04 | 26 | 124 | 3 | IPR026823 | |
| Domain | IPT | 7.44e-04 | 27 | 124 | 3 | SM00429 | |
| Domain | fn3 | 7.46e-04 | 162 | 124 | 6 | PF00041 | |
| Domain | TB | 8.98e-04 | 7 | 124 | 2 | PF00683 | |
| Domain | Spectrin_repeat | 9.20e-04 | 29 | 124 | 3 | IPR002017 | |
| Domain | Semap_dom | 1.12e-03 | 31 | 124 | 3 | IPR001627 | |
| Domain | SEMA | 1.12e-03 | 31 | 124 | 3 | PS51004 | |
| Domain | TIG | 1.12e-03 | 31 | 124 | 3 | PF01833 | |
| Domain | Sema | 1.12e-03 | 31 | 124 | 3 | SM00630 | |
| Domain | Sema | 1.12e-03 | 31 | 124 | 3 | PF01403 | |
| Domain | - | 1.19e-03 | 8 | 124 | 2 | 3.90.290.10 | |
| Domain | Coatomer/calthrin_app_sub_C | 1.19e-03 | 8 | 124 | 2 | IPR009028 | |
| Domain | IPT | 1.23e-03 | 32 | 124 | 3 | IPR002909 | |
| Domain | Plexin_repeat | 1.23e-03 | 32 | 124 | 3 | IPR002165 | |
| Domain | SPEC | 1.23e-03 | 32 | 124 | 3 | SM00150 | |
| Domain | PSI | 1.23e-03 | 32 | 124 | 3 | PF01437 | |
| Domain | Spectrin/alpha-actinin | 1.23e-03 | 32 | 124 | 3 | IPR018159 | |
| Domain | EGF_CA | 1.33e-03 | 122 | 124 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.43e-03 | 124 | 124 | 5 | IPR001881 | |
| Domain | BTK | 1.53e-03 | 9 | 124 | 2 | SM00107 | |
| Domain | Plexin_cytopl | 1.53e-03 | 9 | 124 | 2 | PF08337 | |
| Domain | TB_dom | 1.53e-03 | 9 | 124 | 2 | IPR017878 | |
| Domain | Znf_Btk_motif | 1.53e-03 | 9 | 124 | 2 | IPR001562 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 1.53e-03 | 9 | 124 | 2 | IPR013548 | |
| Domain | Plexin | 1.53e-03 | 9 | 124 | 2 | IPR031148 | |
| Domain | BTK | 1.53e-03 | 9 | 124 | 2 | PF00779 | |
| Domain | ZF_BTK | 1.53e-03 | 9 | 124 | 2 | PS51113 | |
| Domain | TB | 1.53e-03 | 9 | 124 | 2 | PS51364 | |
| Domain | EGF_1 | 1.58e-03 | 255 | 124 | 7 | PS00022 | |
| Domain | EGF-like_CS | 1.80e-03 | 261 | 124 | 7 | IPR013032 | |
| Domain | - | 1.90e-03 | 10 | 124 | 2 | 3.40.50.880 | |
| Domain | EGF_2 | 1.97e-03 | 265 | 124 | 7 | PS01186 | |
| Domain | ARM-like | 2.19e-03 | 270 | 124 | 7 | IPR011989 | |
| Domain | PNMA | 2.31e-03 | 11 | 124 | 2 | IPR026523 | |
| Domain | PNMA | 2.31e-03 | 11 | 124 | 2 | PF14893 | |
| Domain | Coatomer/clathrin_app_Ig-like | 2.76e-03 | 12 | 124 | 2 | IPR013041 | |
| Domain | Class_I_gatase-like | 2.76e-03 | 12 | 124 | 2 | IPR029062 | |
| Domain | Rho_GTPase_activation_prot | 2.81e-03 | 88 | 124 | 4 | IPR008936 | |
| Domain | H15 | 3.25e-03 | 13 | 124 | 2 | SM00526 | |
| Domain | H15 | 3.25e-03 | 13 | 124 | 2 | PS51504 | |
| Domain | Histone_H1/H5_H15 | 3.78e-03 | 14 | 124 | 2 | IPR005818 | |
| Domain | RasGAP | 3.78e-03 | 14 | 124 | 2 | SM00323 | |
| Domain | P_typ_ATPase_c | 3.78e-03 | 14 | 124 | 2 | IPR032630 | |
| Domain | P-type_ATPase_N | 3.78e-03 | 14 | 124 | 2 | IPR032631 | |
| Domain | P-type_ATPase_IV | 3.78e-03 | 14 | 124 | 2 | IPR006539 | |
| Domain | PhoLip_ATPase_C | 3.78e-03 | 14 | 124 | 2 | PF16212 | |
| Domain | PhoLip_ATPase_N | 3.78e-03 | 14 | 124 | 2 | PF16209 | |
| Domain | RasGAP_CS | 3.78e-03 | 14 | 124 | 2 | IPR023152 | |
| Domain | PH | 4.28e-03 | 229 | 124 | 6 | PF00169 | |
| Domain | RasGAP | 4.34e-03 | 15 | 124 | 2 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 4.34e-03 | 15 | 124 | 2 | PS00509 | |
| Domain | RAS_GTPASE_ACTIV_2 | 4.34e-03 | 15 | 124 | 2 | PS50018 | |
| Domain | ASX_HYDROXYL | 4.44e-03 | 100 | 124 | 4 | PS00010 | |
| Domain | EGF | 4.85e-03 | 235 | 124 | 6 | SM00181 | |
| Domain | EGF_3 | 4.85e-03 | 235 | 124 | 6 | PS50026 | |
| Domain | - | 4.94e-03 | 16 | 124 | 2 | 1.10.506.10 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 5.46e-03 | 106 | 124 | 4 | IPR000152 | |
| Domain | GOLGA2L5 | 6.24e-03 | 18 | 124 | 2 | PF15070 | |
| Domain | Golgin_A | 6.24e-03 | 18 | 124 | 2 | IPR024858 | |
| Domain | RasGAP_dom | 6.24e-03 | 18 | 124 | 2 | IPR001936 | |
| Domain | Actin/actin-like_CS | 6.24e-03 | 18 | 124 | 2 | IPR020902 | |
| Domain | EGF-like_dom | 6.39e-03 | 249 | 124 | 6 | IPR000742 | |
| Pubmed | 9.58e-10 | 5 | 131 | 4 | 401950 | ||
| Pubmed | 1.3 A X-ray structure of an antibody Fv fragment used for induced membrane-protein crystallization. | 2.54e-07 | 15 | 131 | 4 | 12657787 | |
| Pubmed | 5.65e-07 | 18 | 131 | 4 | 6788376 | ||
| Pubmed | TICRR MYBBP1A ERCC4 ERP44 RASA2 COPG2 DUS3L STAT1 C2CD5 PPP6C WDHD1 AP1G1 SOCS5 MASTL MACF1 TASOR AGRN | 7.27e-07 | 1084 | 131 | 17 | 11544199 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SMG1 MYBBP1A ERCC4 NUMA1 FYCO1 MED1 C2CD5 NUP205 UBR5 CDC16 ZBTB11 | 9.55e-07 | 440 | 131 | 11 | 34244565 |
| Pubmed | 1.04e-06 | 6 | 131 | 3 | 11409905 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | TICRR NCAPD3 MYBBP1A KAT6A NUMA1 MED1 MAP3K1 NUP205 RIF1 MACF1 CDC6 ZBTB11 TASOR TOP3B | 1.15e-06 | 759 | 131 | 14 | 35915203 |
| Pubmed | SMG1 NCAPD3 ERCC4 SLC4A2 AP1G1 DSTYK MARF1 KMT2A FKBP8 AP4B1 ZBTB11 TASOR AGRN | 1.17e-06 | 650 | 131 | 13 | 38777146 | |
| Pubmed | Early onset of somatic mutation in immunoglobulin VH genes during the primary immune response. | 1.33e-06 | 22 | 131 | 4 | 2499654 | |
| Pubmed | Semaphorin-6A controls guidance of corticospinal tract axons at multiple choice points. | 1.81e-06 | 7 | 131 | 3 | 19063725 | |
| Pubmed | 1.88e-06 | 152 | 131 | 7 | 34299191 | ||
| Pubmed | NCAPD3 MYBBP1A FYCO1 PSMD13 MED1 CPT1A ITGB7 ACTR3 SLC4A2 NUP205 ATP11B AP1G1 UBR5 MARF1 ABCD1 FKBP8 CTPS1 | 2.00e-06 | 1168 | 131 | 17 | 19946888 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | NCAPD3 MYBBP1A ERP44 COPG2 CPT1A SLC4A2 NUP205 TRAFD1 CTPS2 PPP6C AP1G1 UBR5 ABCD1 FKBP8 TARBP1 | 2.85e-06 | 942 | 131 | 15 | 31073040 |
| Pubmed | Trio GEF mediates RhoA activation downstream of Slit2 and coordinates telencephalic wiring. | 2.88e-06 | 8 | 131 | 3 | 30177526 | |
| Pubmed | 4.31e-06 | 9 | 131 | 3 | 19909241 | ||
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 7.26e-06 | 262 | 131 | 8 | 36880596 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | ERP44 KIF1B TWF2 PSMD13 DUS3L ME1 ACTR3 STAT1 NUP205 CTPS2 PPP6C WDHD1 AP1G1 ANP32E MACF1 CTPS1 RASAL1 GABPA | 9.29e-06 | 1455 | 131 | 18 | 22863883 |
| Pubmed | MYBBP1A TRIO COPG2 PSMD13 ITGA5 ME1 ACTR3 CTDSP2 PTPDC1 RIF1 PPP6C PTPRM PLEKHA1 FKBP8 TOP3B | 1.03e-05 | 1049 | 131 | 15 | 27880917 | |
| Pubmed | VPS13C NUMA1 COPG2 TWF2 CPT1A STAT1 UBR5 MOB3B PLEKHA1 ABCD1 FKBP8 | 1.09e-05 | 568 | 131 | 11 | 37774976 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 12399449 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 21851253 | ||
| Pubmed | Plexin/neuropilin complexes mediate repulsion by the axonal guidance signal semaphorin 3A. | 1.41e-05 | 2 | 131 | 2 | 10781943 | |
| Pubmed | New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis. | 1.41e-05 | 2 | 131 | 2 | 30044367 | |
| Pubmed | Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils. | 1.41e-05 | 2 | 131 | 2 | 21440062 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 15131124 | ||
| Pubmed | Microfibril structure masks fibrillin-2 in postnatal tissues. | 1.41e-05 | 2 | 131 | 2 | 20404337 | |
| Pubmed | Fibrillln mutations in Marfan syndrome and related phenotypes. | 1.41e-05 | 2 | 131 | 2 | 8791520 | |
| Pubmed | Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18. | 1.41e-05 | 2 | 131 | 2 | 8307578 | |
| Pubmed | Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. | 1.41e-05 | 2 | 131 | 2 | 7744963 | |
| Pubmed | Specific cleavage of agrin by neurotrypsin, a synaptic protease linked to mental retardation. | 1.41e-05 | 2 | 131 | 2 | 17586728 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 26408953 | ||
| Pubmed | Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration. | 1.41e-05 | 2 | 131 | 2 | 18006876 | |
| Pubmed | Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis. | 1.41e-05 | 2 | 131 | 2 | 24833718 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 24265020 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 20529844 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 39505971 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 23133647 | ||
| Pubmed | Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. | 1.41e-05 | 2 | 131 | 2 | 1852206 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 12920182 | ||
| Pubmed | Kalirin and Trio proteins serve critical roles in excitatory synaptic transmission and LTP. | 1.41e-05 | 2 | 131 | 2 | 26858404 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 24150941 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 23022329 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 12429739 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 18230682 | ||
| Pubmed | Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development. | 1.41e-05 | 2 | 131 | 2 | 12524050 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 10806390 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 8120105 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 35419902 | ||
| Pubmed | Fibrillin assembly: dimer formation mediated by amino-terminal sequences. | 1.41e-05 | 2 | 131 | 2 | 10504303 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 27185879 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 35697767 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 36609795 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 28852218 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 21885656 | ||
| Pubmed | Immunohistochemical expression of fibrillin-1 and fibrillin-2 during tooth development. | 1.41e-05 | 2 | 131 | 2 | 25524144 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 27380275 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 19303856 | ||
| Pubmed | Fibrillins 1 and 2 perform partially overlapping functions during aortic development. | 1.41e-05 | 2 | 131 | 2 | 16407178 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 10359653 | ||
| Pubmed | Regulation of human cytidine triphosphate synthetase 2 by phosphorylation. | 1.41e-05 | 2 | 131 | 2 | 20739275 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | NCAPD3 MYBBP1A NUMA1 COPG2 ACTR3 NUP205 CTPS2 WDHD1 AP1G1 UBR5 ANP32E CTPS1 | 1.53e-05 | 704 | 131 | 12 | 29955894 |
| Pubmed | 1.57e-05 | 210 | 131 | 7 | 16565220 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ACACB NUMA1 PSMD13 ME1 TRAFD1 KMT2A ADGRF3 FKBP8 CTPS1 TOP3B | 2.00e-05 | 497 | 131 | 10 | 36774506 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | NCAPD3 MYBBP1A ERP44 PSMD13 CPT1A STAT1 ITPA NUP205 RIF1 TRAFD1 CTPS2 PPP6C UBR5 FKBP8 CDC6 CTPS1 | 2.16e-05 | 1257 | 131 | 16 | 37317656 |
| Pubmed | 2.17e-05 | 399 | 131 | 9 | 37536630 | ||
| Pubmed | SMG1 MYBBP1A ERCC4 SLF1 ACACB NUMA1 PSMD13 ACTR3 STAT1 NUP205 RIF1 FBN1 FBN2 PPP6C MARF1 KMT2A GABPA | 2.76e-05 | 1429 | 131 | 17 | 35140242 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MYBBP1A ERP44 KIF1B COPG2 TWF2 PSMD13 ACTR3B ACTR3 STAT1 C2CD5 NUP205 UBR5 DSTYK MOB3B AP4B1 CTPS1 | 2.79e-05 | 1284 | 131 | 16 | 17353931 |
| Pubmed | ERP44 ACACB VPS13C COPG2 TWF2 ACTR3 C2CD5 TRAFD1 WDHD1 AP1G1 PLEKHA1 FKBP8 CDC6 GABPA | 2.82e-05 | 1007 | 131 | 14 | 34597346 | |
| Pubmed | VPS13C RNF17 ITPA NUP205 AP1G1 UBR5 CDC16 ASTN1 ABCD1 FKBP8 CTPS1 TASOR | 2.98e-05 | 754 | 131 | 12 | 35906200 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCAPD3 MYBBP1A KIF1B NUMA1 MED1 C2CD5 RIF1 TRAFD1 WDHD1 KMT2A CTPS1 KAT6B | 3.84e-05 | 774 | 131 | 12 | 15302935 |
| Pubmed | 3.87e-05 | 50 | 131 | 4 | 23658023 | ||
| Pubmed | 3.89e-05 | 242 | 131 | 7 | 34011540 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | COPG2 FYCO1 ACTR3B ACTR3 STAT1 MAP3K1 PTPDC1 TRAFD1 CTPS2 PPP6C WDHD1 AP1G1 UBR5 AP4B1 | 3.92e-05 | 1038 | 131 | 14 | 26673895 |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 27397516 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 22195034 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 10825173 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 23271704 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 16179339 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 31801062 | ||
| Pubmed | Construction of a D2.B6-Fv-2r congenic mouse strain: nonlethality of the homozygous Fv-2' genotype. | 4.21e-05 | 3 | 131 | 2 | 6939921 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 33391546 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 29091353 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 30201140 | ||
| Pubmed | Plexins promote Hedgehog signaling through their cytoplasmic GAP activity. | 4.21e-05 | 3 | 131 | 2 | 36169302 | |
| Pubmed | GA binding protein regulates interleukin 7 receptor alpha-chain gene expression in T cells. | 4.21e-05 | 3 | 131 | 2 | 15361867 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 33345773 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 10871287 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 23063713 | ||
| Pubmed | Regulation of Aurora-A kinase gene expression via GABP recruitment of TRAP220/MED1. | 4.21e-05 | 3 | 131 | 2 | 16574658 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 25378636 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 20855508 | ||
| Pubmed | MORF and MOZ acetyltransferases target unmethylated CpG islands through the winged helix domain. | 4.21e-05 | 3 | 131 | 2 | 36754959 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 8806646 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 18625214 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 22784990 | ||
| Pubmed | Differential expression of plexin-A subfamily members in the mouse nervous system. | 4.21e-05 | 3 | 131 | 2 | 11241833 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 29433732 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 33036024 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 28422712 | ||
| Pubmed | LAV-BPIFB4 isoform modulates eNOS signalling through Ca2+/PKC-alpha-dependent mechanism. | 4.21e-05 | 3 | 131 | 2 | 28419216 | |
| Interaction | DVL2 interactions | VPS13C NUMA1 ATP9B PSMD13 REV3L ESCO1 ACTR3 MAP3K1 MST1R HMCN1 AP1G1 MACF1 FKBP8 AGRN TOP3B | 2.59e-06 | 557 | 128 | 15 | int:DVL2 |
| GeneFamily | Fibronectin type III domain containing | 1.22e-04 | 160 | 87 | 6 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.27e-04 | 161 | 87 | 6 | 593 | |
| GeneFamily | Plexins | 8.06e-04 | 9 | 87 | 2 | 683 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 1.00e-03 | 10 | 87 | 2 | 830 | |
| GeneFamily | Paraneoplastic Ma antigens | 1.22e-03 | 11 | 87 | 2 | 671 | |
| GeneFamily | ATPase phospholipid transporting | 2.31e-03 | 15 | 87 | 2 | 1210 | |
| GeneFamily | Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases | 2.63e-03 | 16 | 87 | 2 | 66 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.97e-03 | 17 | 87 | 2 | 486 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SMG1 SLF1 RASA2 VPS13C KAT6A NUMA1 TWF2 REV3L MED1 ITGB7 ACTR3 STAT1 SLC5A3 RIF1 ATP11B UBR5 CDC16 DSTYK KMT2A ANP32E MACF1 AP4B1 KAT6B TASOR GABPA IL7R | 1.75e-08 | 1492 | 130 | 26 | M40023 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | TRIO KAT6A REV3L MED1 C2CD5 RIF1 ATP11B WDHD1 PTPRM UBR5 CDC16 SOCS5 MACF1 KAT6B ZBTB11 TASOR IL7R | 1.20e-06 | 856 | 130 | 17 | M4500 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | DDR1 ERCC4 TRIO KALRN KIF1B FYCO1 CPT1A STAT1 SLC5A3 ZSCAN29 PTPDC1 PTPRM TBC1D22A MARF1 MASTL MOB3B PLEKHA1 ASTN1 FKBP8 | 2.20e-06 | 1102 | 130 | 19 | M2369 |
| Coexpression | YAGI_AML_WITH_T_8_21_TRANSLOCATION | SMG1 DDR1 ZNF274 TRIO NUMA1 PROZ SOCS5 KMT2A MACF1 FKBP8 AGRN | 2.62e-06 | 372 | 130 | 11 | M19261 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | DDR1 ERCC4 TRIO KALRN KIF1B FYCO1 CPT1A STAT1 SLC5A3 ZSCAN29 PTPDC1 PTPRM TBC1D22A MARF1 MASTL MOB3B PLEKHA1 ASTN1 FKBP8 | 2.93e-06 | 1124 | 130 | 19 | MM1070 |
| Coexpression | GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN | 4.83e-06 | 189 | 130 | 8 | M3112 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6 | 1.21e-05 | 102 | 130 | 6 | MM872 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | TRIO KAT6A REV3L C2CD5 ATP11B UBR5 SOCS5 MARF1 KAT6B TASOR IL7R | 2.17e-05 | 466 | 130 | 11 | M13522 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | SMG1 ZNF274 NUMA1 ATP9B MED1 MAP3K1 RIF1 ATP11B AP1G1 KAT6B ZBTB11 | 2.54e-05 | 474 | 130 | 11 | M40991 |
| Coexpression | GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP | 3.83e-05 | 184 | 130 | 7 | M9005 | |
| Coexpression | LEE_BMP2_TARGETS_DN | NCAPD3 MYBBP1A SLF1 PRSS12 ME1 POF1B MOAP1 NUP205 RIF1 WDHD1 ANP32E BMPER CDC6 CTPS1 TARBP1 | 4.37e-05 | 904 | 130 | 15 | M2325 |
| Coexpression | LEE_BMP2_TARGETS_DN | NCAPD3 MYBBP1A SLF1 PRSS12 ME1 POF1B MOAP1 NUP205 RIF1 WDHD1 ANP32E BMPER CDC6 CTPS1 TARBP1 | 5.46e-05 | 922 | 130 | 15 | MM1068 |
| Coexpression | GSE12366_GC_VS_NAIVE_BCELL_DN | 5.53e-05 | 195 | 130 | 7 | M3170 | |
| Coexpression | GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_UP | 5.71e-05 | 196 | 130 | 7 | M4530 | |
| Coexpression | GSE12366_GC_VS_MEMORY_BCELL_DN | 5.90e-05 | 197 | 130 | 7 | M3173 | |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN | 6.29e-05 | 199 | 130 | 7 | M3445 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 6.49e-05 | 200 | 130 | 7 | M9121 | |
| Coexpression | BMI1_DN.V1_UP | 9.46e-05 | 147 | 130 | 6 | M2782 | |
| Coexpression | DING_LUNG_CANCER_BY_MUTATION_RATE | 1.28e-04 | 20 | 130 | 3 | M1189 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP | 1.47e-04 | 228 | 130 | 7 | M2151 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | PCSK1 TICRR NCAPD3 SLF1 REV3L C2CD5 NUP205 PTPDC1 RIF1 WDHD1 CDC6 CTPS1 | 1.50e-04 | 680 | 130 | 12 | MM456 |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | ZNF274 RASA2 KIF1B KAT6A ESCO1 CTDSP2 RIF1 ATP11B PPP6C AP1G1 MARF1 ZBTB11 | 1.50e-04 | 680 | 130 | 12 | M41089 |
| Coexpression | XU_CREBBP_TARGETS_DN | 1.74e-04 | 56 | 130 | 4 | MM642 | |
| Coexpression | GSE37563_WT_VS_CTLA4_KO_CD4_TCELL_D4_POST_IMMUNIZATION_UP | 1.84e-04 | 166 | 130 | 6 | M9015 | |
| Coexpression | SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12 | 1.94e-04 | 318 | 130 | 8 | M2429 | |
| Coexpression | CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP | 1.96e-04 | 239 | 130 | 7 | M4716 | |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | TICRR NCAPD3 ACTR3B NUP205 RIF1 WDHD1 MASTL PLEKHA1 CDC6 CTPS1 | 4.08e-06 | 258 | 129 | 10 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_k2_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | NCAPD3 COPG2 ACTR3B RNF17 NUP205 RIF1 WDHD1 UBR5 PLEKHA1 CTPS1 | 3.72e-05 | 333 | 129 | 10 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000 |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.38e-09 | 200 | 131 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.98e-07 | 165 | 131 | 7 | 26c750f10f6401752e2e63d91dc844c81b29d735 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-06 | 184 | 131 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 195 | 131 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 195 | 131 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 5.72e-06 | 151 | 131 | 6 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.90e-06 | 156 | 131 | 6 | f894fac4e44a23718b20ad80c9677bf4f2118002 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.29e-05 | 174 | 131 | 6 | feed99acd868db61f045e666dbfdcaed91ca1488 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.33e-05 | 175 | 131 | 6 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | BAL-Control-cDC_1|Control / Compartment, Disease Groups and Clusters | 1.42e-05 | 177 | 131 | 6 | aa021f6d62e9d740c5ea499faaf875de835a2865 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-05 | 181 | 131 | 6 | 7286700396676fdc41d9723979b8b408177aceb9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.66e-05 | 182 | 131 | 6 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-05 | 185 | 131 | 6 | a6874dd3030d04380cc3c01de1069461aad4ef45 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.88e-05 | 186 | 131 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.99e-05 | 188 | 131 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.05e-05 | 189 | 131 | 6 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.05e-05 | 189 | 131 | 6 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | PBMC-Severe-cDC_12|Severe / Compartment, Disease Groups and Clusters | 2.11e-05 | 190 | 131 | 6 | 84ee185939bdefb10705b621a70da27701eadcee | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-05 | 191 | 131 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-05 | 191 | 131 | 6 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-05 | 191 | 131 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-05 | 192 | 131 | 6 | 1ee4783051ec94ea94600f040edcb385fc4289f1 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.24e-05 | 192 | 131 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 193 | 131 | 6 | 59b8186d0221fba06a16157e9d148399ed801f38 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 193 | 131 | 6 | dc92680b4bb9fc26430c92e03adb839c8c3b3b98 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 193 | 131 | 6 | 03678162648bd5b1d65a5450b60c8863edbf95c7 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.38e-05 | 194 | 131 | 6 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.38e-05 | 194 | 131 | 6 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-05 | 194 | 131 | 6 | b0c15e7e4bcf30856fb628dedd7ba82df33489f5 | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 2.45e-05 | 195 | 131 | 6 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-05 | 195 | 131 | 6 | 818bc18c5834238e5f733cac6fe928ed0788f57d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-05 | 195 | 131 | 6 | 77e47d2e8b3eb7f7c9620369ccaf87581f923bdb | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 2.52e-05 | 196 | 131 | 6 | ac2c4a325efa8497a755cd31fb6a9d94d8e3bf42 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 196 | 131 | 6 | 7cbb19108b4553ef60ef5c230a29de1662c02efe | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.52e-05 | 196 | 131 | 6 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 196 | 131 | 6 | 4cd1e6b7a791e11a40b19f971b7011bd11fe6273 | |
| ToppCell | moderate-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.52e-05 | 196 | 131 | 6 | 9152f4a8a27ff4ee28f231c5ad00eb2edd9ea6da | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.59e-05 | 197 | 131 | 6 | 86a02fd7b4762b3278e5e60b5483b5fc1206e597 | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 2.59e-05 | 197 | 131 | 6 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.67e-05 | 198 | 131 | 6 | 7cddd474416651088a4e08edfc0ac420ff10a5fe | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-Venous_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.74e-05 | 199 | 131 | 6 | 70e05d7c0c68c28754ce0e72434b205aed6287ae | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD4_T_cells|Lymphoid / Condition, Lineage and Cell class | 2.74e-05 | 199 | 131 | 6 | 2e9ee10a069afca5dbd9f0863cf90a66db1a6ffb | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 2.74e-05 | 199 | 131 | 6 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-tip_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.74e-05 | 199 | 131 | 6 | 1c69395c9305b6ecb0a826d46c8e8ec95795ad6d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.74e-05 | 199 | 131 | 6 | 463ba77dc4c85eebb343f29a42c7ac889b0497c9 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 2.82e-05 | 200 | 131 | 6 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 2.82e-05 | 200 | 131 | 6 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.82e-05 | 200 | 131 | 6 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Dendritic_cells-mDC|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.82e-05 | 200 | 131 | 6 | f78968d4b4d907094b2c44dcf5ac557ae94e4484 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4-POLYDENDROCYTE_(Rostral-�migratory_stream-�(RMS)_(Notum))|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.39e-05 | 73 | 131 | 4 | 50a8164d967f2706344adcdc1562dc08c9f16c8f | |
| ToppCell | FLU-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 1.08e-04 | 159 | 131 | 5 | 97c8e16a7ac10ebba96daee97f9fb1d4a404f23b | |
| ToppCell | FLU-Healthy-1|FLU / Virus stimulation, Condition and Cluster | 1.08e-04 | 159 | 131 | 5 | fe2a9f79b058e89214256e736f6e266830cdfa28 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.08e-04 | 159 | 131 | 5 | 5c7a099aa84ecc62bf9b5e1609e5b6b77889f175 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.21e-04 | 163 | 131 | 5 | 476e94e1d132eaaecb9e376bd32748a75ad22081 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.28e-04 | 165 | 131 | 5 | 9d2bdc42c13c8c2a68889bec8612a1ce56f659fa | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.32e-04 | 166 | 131 | 5 | b64ab3d13b76bba3c305ebbfc96f983cd6ca30c9 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.32e-04 | 166 | 131 | 5 | 26f3d5e5e30b63b09b89cda23c423d12d887631f | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-04 | 167 | 131 | 5 | 53e32d6687a07f486141df9f4ab998af4c03a507 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_E|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-04 | 168 | 131 | 5 | d8f485f8459532a2cb0bef899e6569142cf75685 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l48|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.47e-04 | 170 | 131 | 5 | 070d8683d1a5cc7d594ff0453c961a9bf982c2d0 | |
| ToppCell | droplet-Heart-4Chambers-21m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 171 | 131 | 5 | e852d0e8589eecf4a2e5fea039b52a67c5d58dbd | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.51e-04 | 171 | 131 | 5 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-T_cells-ILC3|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.51e-04 | 171 | 131 | 5 | 6ab7f103cbdbd49ef687cbb8a42ddc5517af0f7f | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-NK_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.55e-04 | 172 | 131 | 5 | a126dacd94939851de1403d30f0b63eaad48bfa1 | |
| ToppCell | facs-GAT-Fat-18m-Lymphocytic-T_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 172 | 131 | 5 | 17a486c5d0430abb133eab9f087e2ef8b60f7d25 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.55e-04 | 172 | 131 | 5 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.64e-04 | 174 | 131 | 5 | 1d157f7a919c8246e83d8060d2a0017c6c781ef3 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 176 | 131 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | -IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.78e-04 | 177 | 131 | 5 | ae2d2e138946535596fa30a55207f261cafda461 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 178 | 131 | 5 | a9a8567d8fdc0fffd612fee16b5b29ef7b1c9307 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 178 | 131 | 5 | 5ecbea15efd304057aef826ec2f385997bfaf0c9 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Activated_DCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.92e-04 | 180 | 131 | 5 | aae85fb3c92a45614616a3ee3a1af5244cc299a7 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.92e-04 | 180 | 131 | 5 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-04 | 180 | 131 | 5 | 8cef63866c205df3825df84ce51fa61aa04ae491 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-immature_innate_lymphoid_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.97e-04 | 181 | 131 | 5 | c7ad10a696d94b9ee91cd7e62761d356d5106eda | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 1.97e-04 | 181 | 131 | 5 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 1.97e-04 | 181 | 131 | 5 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-immature_innate_lymphoid_cell-Ly6g5b+_T|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.97e-04 | 181 | 131 | 5 | eaa3a2c268cce527004ae656d35e037b984fb4c7 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.02e-04 | 182 | 131 | 5 | 997d37ca2af661c92a56add888762724dfccc890 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.02e-04 | 182 | 131 | 5 | b86690c109cdc16844a6cd2216c1bf2bf28efd45 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-04 | 183 | 131 | 5 | dc19857b66dcadbf7c87de91f7b1f4e8ef2857ed | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-04 | 183 | 131 | 5 | 4759560e5b4f4e5a00e5f933e3451a27c7c4aefe | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Ly6g5b+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-04 | 183 | 131 | 5 | 302bd0f1f8025f385a764f2a9adafdd7f1f67ea3 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.13e-04 | 184 | 131 | 5 | 25ccf08a8a26d7e7827b6357f33a53aaf423577d | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.13e-04 | 184 | 131 | 5 | 15f2c10101ccc8ed059520fc082ee42593dff269 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.13e-04 | 184 | 131 | 5 | a90a58d9e319afa1cd572e4c2f516fadc42f56e5 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-B_cells-Pre-B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.18e-04 | 185 | 131 | 5 | 0fa7970709dc957dea95fabbd83263a0335babd5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.23e-04 | 186 | 131 | 5 | 84ba666237c18189d7e7556bd92dd953af733c00 | |
| ToppCell | droplet-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-04 | 186 | 131 | 5 | 26f1e9930adf2fe4af0819e56f69915bd8330e4a | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.23e-04 | 186 | 131 | 5 | bbb8edea8d8bdc1a469faec1563e40b1f62d7f3d | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-innate_lymphocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.23e-04 | 186 | 131 | 5 | 855c2e5a8a6cf94c7de31982e0e2416f924439d3 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 2.29e-04 | 187 | 131 | 5 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 2.29e-04 | 187 | 131 | 5 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.35e-04 | 188 | 131 | 5 | 6844cebca177fdf38b21a40d606230a033717a3a | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.35e-04 | 188 | 131 | 5 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.41e-04 | 189 | 131 | 5 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | COVID-19-Heart-EC_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.41e-04 | 189 | 131 | 5 | fe49852ba15f948b384d6b4c258927c70b741357 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-04 | 189 | 131 | 5 | aadb7a2de4cbe7f0958651f2739bba430b93f5c1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.41e-04 | 189 | 131 | 5 | 12b6f1c3bf526b90e112374bf937701f645c5780 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.41e-04 | 189 | 131 | 5 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| Disease | lymphangioleiomyomatosis (is_marker_for) | 1.67e-05 | 12 | 127 | 3 | DOID:3319 (is_marker_for) | |
| Disease | body surface area | PCSK1 PAPPA2 TICRR COL24A1 FBN1 FBN2 TNFSF13B MACF1 CTPS1 TASOR TSEN15 ECE2 | 2.28e-05 | 643 | 127 | 12 | EFO_0022196 |
| Disease | connective tissue disease (implicated_via_orthology) | 5.50e-05 | 3 | 127 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | scoliosis (is_implicated_in) | 1.10e-04 | 4 | 127 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | Vesico-Ureteral Reflux | 1.10e-04 | 4 | 127 | 2 | C0042580 | |
| Disease | Liver carcinoma | 3.59e-04 | 507 | 127 | 9 | C2239176 | |
| Disease | Behcet's disease (is_implicated_in) | 5.01e-04 | 36 | 127 | 3 | DOID:13241 (is_implicated_in) | |
| Disease | Secondary Biliary Cholangitis | 7.91e-04 | 42 | 127 | 3 | C0238065 | |
| Disease | Biliary cirrhosis | 7.91e-04 | 42 | 127 | 3 | C0023892 | |
| Disease | Biliary Cirrhosis, Primary, 1 | 7.91e-04 | 42 | 127 | 3 | C4551595 | |
| Disease | Primary biliary cirrhosis | 1.10e-03 | 47 | 127 | 3 | C0008312 | |
| Disease | lean body mass | 1.31e-03 | 379 | 127 | 7 | EFO_0004995 | |
| Disease | tumor necrosis factor ligand superfamily member 11 measurement | 1.39e-03 | 13 | 127 | 2 | EFO_0010617 | |
| Disease | Prostatic Neoplasms | 1.42e-03 | 616 | 127 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.42e-03 | 616 | 127 | 9 | C0376358 | |
| Disease | pulse pressure measurement, social deprivation | 1.62e-03 | 14 | 127 | 2 | EFO_0005763, EFO_0009696 | |
| Disease | Spastic Paraplegia, Hereditary | 1.62e-03 | 14 | 127 | 2 | C0037773 | |
| Disease | birth weight | 1.75e-03 | 399 | 127 | 7 | EFO_0004344 | |
| Disease | glycerate measurement | 1.86e-03 | 15 | 127 | 2 | EFO_0021029 | |
| Disease | cortical surface area measurement | TICRR NCAPD3 PRSS12 KIF1B STAT1 MAP3K1 COL24A1 FBN1 FBN2 TBC1D22A DSTYK MACF1 ROBO2 PLXNA2 | 1.99e-03 | 1345 | 127 | 14 | EFO_0010736 |
| Disease | Rolandic epilepsy | 2.12e-03 | 16 | 127 | 2 | Orphanet_1945 | |
| Disease | neuroimaging measurement | PRSS12 KIF1B REV3L GTDC1 STAT1 MAP3K1 COL24A1 FBN2 DSTYK MACF1 ROBO2 PLXNA2 | 2.27e-03 | 1069 | 127 | 12 | EFO_0004346 |
| Disease | androstenedione measurement, estrone measurement | 2.69e-03 | 18 | 127 | 2 | EFO_0007970, EFO_0007972 | |
| Disease | body weight | PCSK1 PAPPA2 RASA2 VPS13C ACTR3B FBN2 TNFSF13B CDC16 PLEKHA1 KAT6B TSEN15 NOS3 PLXNA1 | 3.12e-03 | 1261 | 127 | 13 | EFO_0004338 |
| Disease | ascending aortic diameter | 3.20e-03 | 140 | 127 | 4 | EFO_0021787 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 3.80e-03 | 147 | 127 | 4 | DOID:9352 (biomarker_via_orthology) | |
| Disease | breast cancer (is_implicated_in) | 4.09e-03 | 150 | 127 | 4 | DOID:1612 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QELGREIALPIEACV | 291 | Q6ZT62 | |
| EIGAQVCAEELEPAA | 141 | Q6PI77 | |
| PENAEATVVLVGCVE | 511 | P04920 | |
| ITIIQDGDITCPEDA | 421 | Q8IZF5 | |
| LCPIVDVVLGLVNDQ | 331 | P59827 | |
| ISDVVDEVIQNCPID | 296 | Q9P1U1 | |
| DPNIIRLLGVCVQDD | 681 | Q08345 | |
| ESNIEDPLIVTPDCQ | 601 | Q96GX5 | |
| LQQTQIEEARAGPCE | 651 | O00468 | |
| QDPIVVVNCLRSLEE | 171 | Q9Y6B7 | |
| DIPGECQEVIETSLN | 521 | P50416 | |
| DQLQELCIPQDLVGD | 111 | Q9GZQ3 | |
| PEEVTELVLDNCLCV | 16 | Q9BTT0 | |
| NLDIGAQLIVEECPS | 6 | Q9H9E1 | |
| EVDFVDINVGCPIDL | 386 | Q96G46 | |
| SPVQDDIDSILVQCG | 376 | Q9H7Y0 | |
| VATVPLENQCLEEIS | 776 | O14525 | |
| DPDAEVQGEICLSVQ | 111 | O95294 | |
| CTAGVPADIQIDIDE | 741 | Q15283 | |
| EIILTACPQDLIQAE | 1291 | Q92621 | |
| QLEPTCEIEVEEDGR | 1171 | Q8WYB5 | |
| EVQINNEEIFPTCVG | 126 | Q86TA1 | |
| QVVDVEQGIICENIP | 466 | P33897 | |
| RGLVEENPEVAVDCV | 2416 | O00763 | |
| LLVSGQCEEEEPIQV | 486 | O43747 | |
| PNCVTNLEILLEDTV | 131 | Q9Y5G9 | |
| DIALVRLQGPEEQCA | 726 | P56730 | |
| QECLPVILDVGTENE | 186 | P48163 | |
| VLQEICDEVNLPLLT | 186 | Q9BRQ3 | |
| VAILEGVQCEVQLVE | 11 | P01780 | |
| EELCQIQESGSSLPE | 1286 | Q9BQS8 | |
| ECVSQAIDINEPIGN | 36 | Q06546 | |
| QEESQAGIIPQLCEE | 111 | O60333 | |
| CLTGVEDQLQADVRP | 736 | O43861 | |
| EQIIVEVFEQCGEII | 141 | Q16206 | |
| VAILEGVQCEVQLVE | 11 | P01766 | |
| SCLQVERIEELGAQP | 226 | P0DPD6 | |
| VAILEGVQCEVQLVE | 11 | P01763 | |
| PLITVDECLQALEEV | 226 | Q96BY2 | |
| LEGRVNVSEDCPQIL | 696 | Q9UIW2 | |
| QEGRINISEDCPQLV | 691 | O75051 | |
| NISEDCPQLVPTEEI | 696 | O75051 | |
| GCLETKQDNLPDIEV | 261 | Q8N1A0 | |
| LNLVSPLGCEVDVEE | 496 | Q8NDH3 | |
| AEQLAQTGECDPEEI | 601 | O60229 | |
| CEEGVTPLVELQNQI | 476 | O94854 | |
| VEVEEGESVVLPCNP | 146 | P32004 | |
| EQEERLCEQEKLPGQ | 231 | A6NEM1 | |
| QEERLCEQEKLPGQE | 316 | A6NI86 | |
| DPDVNITNLEFEICG | 61 | P16871 | |
| CIVNLQTIPVDVEEA | 691 | A2A3K4 | |
| GCVDIKDLPVSEQQE | 181 | Q9UNM6 | |
| VAILEGVQCEVQLVE | 11 | A0A0B4J1V1 | |
| SQICEQVIIQDDGPE | 236 | Q8WVV4 | |
| LLQEVDVVVAPCQGL | 216 | Q6XUX3 | |
| CAGPEEQELSLQEEV | 411 | Q9UHF4 | |
| EGCQDDPERQLAVLV | 361 | Q9BQG0 | |
| EEISVIVNNPLELTC | 3536 | Q96RW7 | |
| CPLEELEEPRGQQEV | 91 | P26010 | |
| VRGDPANVEITELCI | 261 | P29474 | |
| VVLPDCELNTLDQIA | 131 | Q6ZMV5 | |
| QCPREEDIVEVQGSP | 91 | Q9Y2Y8 | |
| GEDNICVPDLQLEVF | 646 | P08648 | |
| EPQCQERELEISVGK | 801 | Q92794 | |
| NICDDEGLNPIVSEE | 531 | Q9BXP8 | |
| PESVDGLQENLDVVV | 221 | Q13042 | |
| ISEVVDEVIQNCPID | 296 | P61158 | |
| RVQEEPELVFTLGDC | 136 | Q14318 | |
| SVAKCENEGEVLQIP | 46 | Q8N8U9 | |
| EPCVLRQCQEGVVTE | 126 | Q8N8U9 | |
| VKGENLEAVVCEEPQ | 226 | Q8TCZ2 | |
| LPEVTEEDQGRICVV | 91 | O14595 | |
| SNRCIQEVGLQEDPL | 251 | Q6ZNG2 | |
| TVILEDIDECQELPG | 1601 | P35555 | |
| PDEFVSCLGIVNEEL | 591 | Q5VWK5 | |
| IAQEICQEEVSRPAG | 246 | Q99741 | |
| AIVDCIISIVEENPE | 416 | Q9UBF2 | |
| CVPLVREITFENGEE | 241 | Q9BS26 | |
| EAIPDTLQVLECGEE | 1311 | Q9Y4F3 | |
| VRQVQGPVLVEDTCL | 61 | Q9BY32 | |
| EEQCDLPKISQLDGV | 2706 | Q03164 | |
| GSILQLCEEIAGEIE | 301 | Q5FWF5 | |
| PNPITIILEDIDECQ | 1641 | P35556 | |
| QLVDLLQEELGDCVV | 16 | Q4AE62 | |
| SQLVDEVVCALQPVI | 76 | Q9NV23 | |
| DVEIQATDICDPNPI | 1841 | Q6ZTR5 | |
| VEGCLEQRLEENLPT | 446 | Q86YS7 | |
| IEPLNEVQSCEGLRD | 36 | Q6ZN68 | |
| EVQLDPAGQLCDVKV | 111 | Q15648 | |
| QELIVQTDEDLPGAV | 471 | P28827 | |
| ADPVEAVLQLQDCSI | 21 | Q14980 | |
| ENGEDIIIIQQDTPE | 1211 | Q13233 | |
| ETQLCQPGLVIDLET | 436 | P42224 | |
| IIIPCEFCGVQLEEE | 366 | O14545 | |
| NCATEIPQIVEISIE | 81 | O75159 | |
| DSDIVIPQDVTEDCG | 1126 | Q5UIP0 | |
| IPEGLEQADVEAVLQ | 26 | Q9ULN7 | |
| LGNIQGEELLVSECE | 1886 | Q96Q15 | |
| IPVDEDGLEPQVCVI | 131 | P17812 | |
| EDVNLLVTCREEGNP | 601 | P53794 | |
| LVEGEECGQVLNVTV | 321 | P22891 | |
| DDVLTGQVEEQCVPA | 991 | Q9UK61 | |
| ETPAEEQELLTQVCG | 811 | P42695 | |
| LDTLVAVIECQQPEA | 201 | Q9Y2G3 | |
| EGIVCQLDIIPSAEA | 216 | Q17RW2 | |
| SEDGENLEILCPVQD | 716 | Q9BXT8 | |
| EGENICFEVLDAVLP | 121 | O95985 | |
| NKEEPQICVIELGGT | 136 | Q9NRF8 | |
| TELGDCEIVLLVNGE | 356 | O95625 | |
| CEIVLLVNGELPEAE | 361 | O95625 | |
| RTPILEDFELEGVCQ | 1731 | Q7Z2Z1 | |
| EGVEPQSTCELEVDA | 226 | O60673 | |
| VCDLLLEESNVQPVS | 31 | O00743 | |
| IIDLPQNEDIEAICL | 526 | O75717 | |
| PENCQEVVALVEGVT | 226 | Q96GC6 | |
| LLCDLPIQVTLEEVN | 16 | Q9BV90 | |
| LIEENCGVVVESIQV | 2271 | Q709C8 | |
| DVVVAAGEPAILECQ | 141 | Q9HCK4 | |
| VDVSGVPAEVLCNIE | 346 | Q8WUA7 | |
| LQRCPEVDLLTQVDG | 861 | Q9BQI6 | |
| ECVPILRELAGVEQA | 226 | Q5W5X9 | |
| ACVDELLELVVQAVP | 356 | Q00G26 | |
| GIPANLIQQLDVCVE | 1571 | Q13395 | |
| DVCVEIPQQGIIRSL | 1581 | Q13395 | |
| ACLVLVLNTQPAEEE | 56 | Q92889 | |
| QCPENGEEAVTLVED | 81 | Q8IWY8 | |
| IITPTQKEEVNECGE | 151 | Q9HB21 | |
| QGPEETVTQDCLQLI | 136 | Q9Y275 | |
| EEFECELEPLGTQAV | 636 | Q04912 | |
| QTEPLCAIQDAEGAI | 236 | Q702N8 | |
| ELQLICLVGTEIEGE | 86 | Q8WW01 | |
| VVGLESQCRPQELDQ | 96 | Q8IV31 | |
| VIEDEQLVLGASQEP | 31 | Q6IBS0 | |
| AEQLAQTGECDPEEI | 631 | O75962 | |
| AVEELCNVAESLIVP | 1471 | O95071 | |
| PVLGENCRLEVIIEE | 651 | Q9UPR5 | |
| ANGEVIIEIPTRACE | 481 | P29120 | |
| IIEIPTRACEGQENA | 486 | P29120 |